Molecular basis of ligand recognition and transport by glucose transporters

Nature

Volumn 526, Issue 7573, 2015, Pages 391-396

  Deng, Dong ^a,b   Sun, Pengcheng ^a,b   Yan, Chuangye ^a,b   Ke, Meng ^a,b   Jiang, Xin ^a   Xiong, Lei ^b   Ren, Wenlin ^a   Hirata, Kunio ^c,d   Yamamoto, Masaki ^c   Fan, Shilong ^a   Yan, Nieng ^a,b  

^a TSINGHUA UNIVERSITY   (China)

^b Tsinghua University   (China)

^c RIKEN SPring 8 Center   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOSE; FUCOSE; GALACTOSE; GLUCOPYRANOSIDE; GLUCOSE; GLUCOSE 6 PHOSPHATE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HYDROGEN; INOSITOL; LIGAND; MALTOSE; MANNOSE; N ACETYLGLUCOSAMINE; XYLOSE; PROTEIN BINDING; RECOMBINANT PROTEIN; SLC2A1 PROTEIN, HUMAN; SLC2A3 PROTEIN, HUMAN;

AMINO ACID; CRYSTAL STRUCTURE; DESIGN; GLUCOSE; LIGAND; MOLECULAR ANALYSIS; PROTEIN; SUBSTRATE;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; GLUCOSE TRANSPORT; HUMAN; HYDROGEN BOND; LIGAND BINDING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; QUALITATIVE ANALYSIS; X RAY DIFFRACTION; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; KINETICS; METABOLISM; ROTATION; STRUCTURE ACTIVITY RELATION; TRANSPORT AT THE CELLULAR LEVEL; X RAY CRYSTALLOGRAPHY;

BINDING SITES; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 3; HUMANS; KINETICS; LIGANDS; MALTOSE; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; ROTATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84938299834     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14655     Document Type: Article

References (65)

1. Nelson, D. L. & Cox, M. M. Lehninger Principles of Biochemistry (W. H. Freeman, 2008).
2. Hediger, M. A., Clemencon, B., Burrier, R. E.& Bruford, E. A. The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol. AspectsMed.34, 95-107 (2013).
3. Mueckler, M. & Thorens, B. The SLC2 (GLUT) family of membrane transporters. Mol. Aspects Med. 34, 121-138 (2013).
4. Manolescu, A. R., Witkowska, K., Kinnaird, A., Cessford, T. & Cheeseman, C. Facilitated hexose transporters: new perspectives on form and function. Physiology 22, 234-240 (2007).
5. LeFevre, P. G. Evidence of active transfer of certain non-electrolytes across the human red cell membrane. J. Gen. Physiol. 31, 505-527 (1948).
6. Kasahara, M. & Hinkle, P. C. Reconstitution and purification of the D-glucose transporter from human erythrocytes. J. Biol. Chem. 252, 7384-7390 (1977).
7. Mueckler, M. et al. Sequence and structure of a human glucose transporter. Science 229, 941-945 (1985).
8. Thorens, B. &Mueckler, M. Glucose transporters in the 21st century.Am. J. Physiol. Endocrinol. Metab. 298, E141-E145 (2010).
9. Dick, A. P., Harik, S. I., Klip, A. & Walker, D. M. Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. Proc. Natl Acad. Sci. USA 81, 7233-7237 (1984).
10. Maher, F., Vannucci, S. J. & Simpson, I. A. Glucose transporter proteins in brain. FASEB J. 8, 1003-1011 (1994).
11. Thorens, B., Sarkar, H. K., Kaback, H. R. & Lodish, H. F. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and b-pancreatic islet cells. Cell 55, 281-290 (1988).
12. Fukumoto, H. et al. Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc. Natl Acad. Sci. USA 85, 5434-5438 (1988).
13. Simpson, I. A. et al. The facilitative glucose transporter GLUT3: 20 years of distinction. Am. J. Physiol. Endocrinol. Metab. 295, E242-E253 (2008).
14. James, D. E., Brown, R., Navarro, J. & Pilch, P. F. Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein.Nature333,183-185(1988).
15. Birnbaum, M. J. Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell 57, 305-315 (1989).
16. Mueckler, M. Facilitative glucose transporters. Eur. J. Biochem. 219, 713-725 (1994).
17. Pascual, J. M. et al. GLUT1 deficiency and other glucose transporter diseases. Eur. J. Endocrinol. 150, 627-633 (2004).
18. Santer, R. et al.Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nature Genet. 17, 324-326 (1997).
19. Simpson, I. A., Chundu, K. R., Davies-Hill, T., Honer, W. G. & Davies, P. Decreased concentrations ofGLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35, 546-551 (1994).
20. Macheda, M. L., Rogers, S.& Best, J. D.Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 202, 654-662 (2005).
21. Amann, T. & Hellerbrand, C. GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin. Ther. Targets 13, 1411-1427 (2009).
22. Shim, B. Y. et al. Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer. Int. J. Colorectal Dis. 28, 375-383 (2013).
23. Ramani, P., Headford, A. & May, M. T. GLUT1 protein expression correlates with unfavourable histologic category and high risk in patients with neuroblastic tumours. Virchows Arch. 462, 203-209 (2013).
24. Flavahan, W. A. et al. Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nature Neurosci. 16, 1373-1382 (2013).
25. Airley, R. E. & Mobasheri, A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 53, 233-256 (2007).
26. Kaira, K. et al. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer. Lung Cancer 83, 197-204 (2013).
27. Gallamini, A., Zwarthoed, C. & Borra, A. Positron emission tomography (PET) in oncology. Cancers 6, 1821-1889 (2014).
28. Calvaresi, E. C. & Hergenrother, P. J. Glucose conjugation for the specific targeting and treatment of cancer. Chem. Sci. 4, 2319-2333 (2013).
29. Jardetzky, O.Simple allostericmodel formembranepumps.Nature211,969-970 (1966).
30. Shi, Y.Commonfolds andtransportmechanismsof secondary active transporters. Annu. Rev. Biophys. 42, 51-72 (2013).
31. Smirnova, I., Kasho, V. & Kaback, H. R. Lactose permease and the alternating access mechanism. Biochemistry 50, 9684-9693 (2011).
32. Deng, D. et al. Crystal structure of the human glucose transporter GLUT1. Nature 510, 121-125 (2014).
33. Sun, L. et al. Crystal structure of a bacterial homologue of glucose transporters GLUT1-4. Nature 490, 361-366 (2012).
34. Quistgaard, E. M., Low, C., Moberg, P., Tresaugues, L. & Nordlund, P. Structural basis for substrate transport in the GLUT-homology family of monosaccharide transporters. Nature Struct. Mol. Biol. 20, 766-768 (2013).
35. Wisedchaisri, G., Park, M. S., Iadanza, M. G., Zheng, H. & Gonen, T. Proton-coupled sugar transport in the prototypical major facilitator superfamily protein XylE. Nature Commun. 5, 4521 (2014).
36. Lacko, L., Wittke, B. & Geck, P. The temperature dependence of the exchange transport of glucose in human erythrocytes. J. Cell. Physiol. 82, 213-218 (1973).
37. Chen, C. C. et al. Human erythrocyte glucose transporter: normal asymmetric orientation and function in liposomes. Proc. Natl Acad. Sci. USA 83, 2652-2656 (1986).
38. Rumsey, S. C. et al. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J. Biol. Chem. 272, 18982-18989 (1997).
39. Rumsey, S. C. et al. Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes. J. Biol. Chem. 275, 28246-28253 (2000).
40. Uldry, M., Ibberson, M., Hosokawa, M. & Thorens, B. GLUT2 is a high affinity glucosamine transporter. FEBS Lett. 524, 199-203 (2002).
41. Maher, F., Davies-Hill, T. M. & Simpson, I. A. Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons. Biochem. J. 315, 827-831 (1996).
42. Yan, N. Structural advances for the major facilitator superfamily (MFS) transporters. Trends Biochem. Sci. 38, 151-159 (2013).
43. Carruthers, A.&Helgerson, A. L. Inhibitions of sugar transport produced by ligands binding atopposite sidesof themembrane. Evidence for simultaneous occupation of the carrier by maltose and cytochalasin B. Biochemistry 30, 3907-3915 (1991).
44. Colville, C. A., Seatter, M. J., Jess, T. J., Gould, G. W. & Thomas, H. M. Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors. Biochem. J. 290, 701-706 (1993).
45. Janoshazi, A. & Solomon, A. K. Initial steps of alpha-and beta-D-glucose binding to intact red cell membrane. J. Membr. Biol. 132, 167-178 (1993).
46. Leitch, J. M. & Carruthers, A. a-and b-monosaccharide transport in human erythrocytes. Am. J. Physiol. Cell Physiol. 296, C151-C161 (2009).
47. Carruthers, A.&Melchior, D. L. Transport of alpha-andbeta-D-glucose by the intact human red cell. Biochemistry 24, 4244-4250 (1985).
48. Barnett, J. E., Holman, G. D. & Munday, K. A. An explanation of the asymmetric binding of sugars to the human erythrocyte sugar-transport systems. Biochem. J. 135, 539-541 (1973).
49. DeLano, W. L. The PyMOL molecular graphics system (Schrödinger, 2002).
50. Smart, O. S., Goodfellow, J. M.&Wallace, B.A. The pore dimensions of gramicidin A. Biophys. J. 65, 2455-2460 (1993).
51. Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nature Protocols 4, 706-731 (2009).
52. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
53. Collaborative Computational Project Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
54. McCoy, A. J. et al.Phaser crystallographic software. J.Appl. Crystallogr.40, 658-674 (2007).
55. Stein, N. CHAINSAW: a program for mutating pdb files used as templates in molecular replacement. J. Appl. Crystallogr. 41, 641-643 (2008).
56. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
57. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948-1954 (2002).
58. Echols, N., Milburn, D. & Gerstein, M. MolMovDB: analysis and visualization of conformational change and structural flexibility. Nucleic Acids Res. 31, 478-482 (2003).
59. Krebs, W. G.& Gerstein, M. Themorph server: a standardized systemfor analyzing and visualizing macromolecular motions in a database framework. Nucleic Acids Res. 28, 1665-1675 (2000).
60. Brünger, A. T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
61. Brünger, A. T.Version1.2 of the Crystallography andNMRsystem.Nature Protocols 2, 2728-2733 (2007).
62. Arnold, K., Bordoli, L.,Kopp, J.&Schwede, T. TheSWISS-MODEL workspace: awebbased environment for protein structure homology modelling. Bioinformatics 22, 195-201 (2006).
63. Schwede, T., Kopp, J., Guex, N. & Peitsch, M. C. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 31, 3381-3385 (2003).
64. Guex, N. & Peitsch, M. C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-2723 (1997).
65. Thompson, J. D., Higgins, D. G.&Gibson, T. J.CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680 (1994).